Biogen Total Assets increased by 0.1% to $29.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $28.03B to $29.48B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 3.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.47B | $23.81B | $23.88B | $23.61B | $25.08B | $24.85B | $24.55B | $24.60B | $25.16B | $28.19B | $26.84B | $26.57B | $26.80B | $28.31B | $28.05B | $28.03B | $28.33B | $29.21B | $29.44B | $29.48B |
| QoQ Change | — | -2.7% | +0.3% | -1.1% | +6.2% | -0.9% | -1.2% | +0.2% | +2.3% | +12.1% | -4.8% | -1.0% | +0.9% | +5.6% | -0.9% | -0.1% | +1.1% | +3.1% | +0.8% | +0.1% |
| YoY Change | — | — | — | — | +2.5% | +4.4% | +2.8% | +4.2% | +0.3% | +13.4% | +9.3% | +8.0% | +6.5% | +0.4% | +4.5% | +5.5% | +5.7% | +3.2% | +5.0% | +5.2% |